Kingdon Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-150,000
Closed -$6.05M 74
2022
Q2
$6.05M Buy
150,000
+50,000
+50% +$2.48M 1.03% 34
2022
Q1
$6.62M Buy
+100,000
New +$6.84M 0.69% 35

Other funds holding GH

Kingdon Capital Management's GH Position: Q4 2024 in Review

Kingdon Capital Management sold out of Guardant Health (GH) in Q4 2024, closing a stake of 485,000 shares — an estimated $11.1M sold.

Kingdon Capital Management first reported a position in GH in Q1 2022 and held it in 5 quarters. The position peaked at $19.4M in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Kingdon Capital Management reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Kingdon Capital Management sold 485,000 Guardant Health shares in Q4 2024, an estimated $11.1M.
  • Kingdon Capital Management first reported a position in Guardant Health in Q1 2022 and held it in 5 quarters.
  • Kingdon Capital Management's Guardant Health position peaked at $19.4M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Kingdon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.